Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-28 @ 6:14 AM
Study NCT ID:
NCT04464967
Status:
WITHDRAWN
Last Update Posted:
2021-05-12
First Post:
2020-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
Sponsor:
NKGen Biotech, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Tumor | View |
| None | Metastatic Cancer | View |
| None | HER2-positive Breast Cancer | View |
| None | HER2-positive Gastric Cancer | View |
| None | HER-2 Protein Overexpression | View |
| None | Esophageal Cancer | View |
| None | Ovarian Cancer | View |
| None | Endometrium Cancer | View |
| None | Bladder Cancer | View |
| None | Pancreatic Cancer | View |
| None | Colorectal Cancer | View |
| None | Non Small Cell Lung Cancer | View |
| None | EGF-R Positive Non-Small Cell Lung Cancer | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | Triple Negative Breast Cancer | View |
| None | Cervical Cancer | View |
| None | Sarcoma | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Natural killer cell | View |
| None | NK cell | View |
| None | Expanded natural killer cell | View |
| None | Immunotherapy | View |
| None | Cancer | View |
| None | Metastatic cancer | View |
| None | Advanced cancer | View |
| None | Recurrent cancer | View |
| None | HER2 Positive | View |
| None | HER2+ | View |
| None | HER2 | View |
| None | EGFR Positive | View |
| None | EGFR+ | View |
| None | EGFR | View |
| None | Solid tumor | View |
| None | Breast Cancer | View |
| None | Gastric Cancer | View |
| None | Esophageal Cancer | View |
| None | Ovarian Cancer | View |
| None | Endometrium Cancer | View |
| None | Bladder Cancer | View |
| None | Pancreatic Cancer | View |
| None | Colorectal Cancer | View |
| None | Non Small Cell Lung Cancer | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | Triple Negative Breast Cancer | View |
| None | Cervical Cancer | View |
| None | Sarcoma | View |